{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:13:38Z","timestamp":1770884018719,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Residual neuromuscular block after using neuromuscular blocking agents is a common and potentially harmful complication of general anesthesia. Neostigmine is a widely used antagonist, but its optimal dose for elderly patients is unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To compare the optimal dosage and safety of neostigmine for reversing shallow residual block in elderly patients after cisatracurium-induced neuromuscular block.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A randomized controlled trial was conducted in 196 elderly patients undergoing non-cardiac surgery under general anesthesia with cisatracurium. Patients were assigned to receive either no neostigmine (control group) or neostigmine at 20\u00a0\u00b5g\/kg, 40\u00a0\u00b5g\/kg or 50\u00a0\u00b5g\/kg when train-of-four (TOF) ratio reached 0.2 at the end of surgery. The primary outcome was the time to reach TOF ratio of 0.9 after administration. Secondary outcomes included TOF ratio at 10\u00a0min after administration, postoperative nausea and vomiting, postoperative cognitive impairment and post-anesthesia care unit (PACU) stay time.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The time to reach TOF ratio of 0.9 in the 20\u00a0\u00b5g\/kg, 40\u00a0\u00b5g\/kg and 50\u00a0\u00b5g\/kg groups was significantly shorter than the control group (H\u2009=\u2009104.257, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01), and the time of 40\u00a0\u00b5g\/kg group and 50\u00a0\u00b5g\/kg group was significantly shorter than the 20\u00a0\u00b5g\/kg group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). There was no significant difference between 40\u00a0\u00b5g\/kg and 50\u00a0\u00b5g\/kg groups (<jats:italic>P<\/jats:italic>\u2009=\u20090.249). The TOF ratio at 10\u00a0min after administration showed similar results. There were no significant differences among groups in postoperative nausea and vomiting, postoperative cognitive impairment or post-operation hospital stay.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Timely use of neostigmine after general anesthesia in elderly patients can significantly shorten time of TOF value reaching 0.9, among which 40\u00a0\u00b5g\/kg dosage may be a more optimized choice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>this study was registered on chictr.org.cn (ChiCTR2100054685, 24\/12\/2021).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12871-023-02233-7","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T07:01:58Z","timestamp":1691650918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Optimal dose of neostigmine antagonizing cisatracurium-induced shallow neuromuscular block in elderly patients: a randomized control study"],"prefix":"10.1186","volume":"23","author":[{"given":"Mengya","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangwen","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"issue":"4","key":"2233_CR1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/00000542-199704000-00005","volume":"86","author":"AF Kopman","year":"1997","unstructured":"Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology. 1997;86(4):765\u201371.","journal-title":"Anesthesiology"},{"issue":"4","key":"2233_CR2","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/00000542-200004000-00014","volume":"92","author":"E Sundman","year":"2000","unstructured":"Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI. The incidence and mechanisms of pharyngeal and upper esophageal dysfunction in partially paralyzed humans: pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology. 2000;92(4):977\u201384.","journal-title":"Anesthesiology"},{"issue":"1","key":"2233_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1213\/ane.0b013e31816d1268","volume":"107","author":"GS Murphy","year":"2008","unstructured":"Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg. 2008;107(1):130\u20137.","journal-title":"Anesth Analg"},{"issue":"5","key":"2233_CR4","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1213\/ANE.0000000000001848","volume":"124","author":"MR Bronsert","year":"2017","unstructured":"Bronsert MR, Henderson WG, Monk TG, Richman JS, Nguyen JD, Sum-Ping JT, Mangione MP, Higley B, Hammermeister KE. Intermediate-Acting Nondepolarizing Neuromuscular blocking agents and risk of postoperative 30-Day morbidity and mortality, and long-term survival. Anesth Analg. 2017;124(5):1476\u201383.","journal-title":"Anesth Analg"},{"issue":"3","key":"2233_CR5","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/bja\/ael386","volume":"98","author":"M Naguib","year":"2007","unstructured":"Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth. 2007;98(3):302\u201316.","journal-title":"Br J Anaesth"},{"key":"2233_CR6","doi-asserted-by":"publisher","first-page":"109818","DOI":"10.1016\/j.jclinane.2020.109818","volume":"64","author":"AD Raval","year":"2020","unstructured":"Raval AD, Uyei J, Karabis A, Bash LD, Brull SJ. Incidence of residual neuromuscular blockade and use of neuromuscular blocking agents with or without antagonists: a systematic review and meta-analysis of randomized controlled trials. J Clin Anesth. 2020;64:109818.","journal-title":"J Clin Anesth"},{"issue":"2","key":"2233_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.arbres.2014.04.016","volume":"51","author":"D Xar\u00e1","year":"2015","unstructured":"Xar\u00e1 D, Santos A, Abelha F. Adverse respiratory events in a post-anesthesia care unit. Arch Bronconeumol. 2015;51(2):69\u201375. English, Spanish.","journal-title":"Arch Bronconeumol"},{"issue":"6","key":"2233_CR8","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1097\/ALN.0000000000000865","volume":"123","author":"GS Murphy","year":"2015","unstructured":"Murphy GS, Szokol JW, Avram MJ, Greenberg SB, Shear TD, Vender JS, Parikh KN, Patel SS, Patel A. Residual neuromuscular block in the Elderly: incidence and clinical implications. Anesthesiology. 2015;123(6):1322\u201336.","journal-title":"Anesthesiology"},{"issue":"3","key":"2233_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/ALN.0000000000002711","volume":"131","author":"SJL Broens","year":"2019","unstructured":"Broens SJL, Boon M, Martini CH, Niesters M, van Velzen M, Aarts LPHJ, Dahan A. Reversal of partial neuromuscular block and the ventilatory response to Hypoxia: a randomized controlled trial in healthy volunteers. Anesthesiology. 2019;131(3):467\u201376.","journal-title":"Anesthesiology"},{"issue":"4","key":"2233_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/anae.13398","volume":"71","author":"ES Choi","year":"2016","unstructured":"Choi ES, Oh AY, Seo KS, Hwang JW, Ryu JH, Koo BW, Kim BG. Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium. Anaesthesia. 2016;71(4):443\u20139.","journal-title":"Anaesthesia"},{"issue":"2","key":"2233_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1124\/pr.56.2.4","volume":"56","author":"AJ McLean","year":"2004","unstructured":"McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56(2):163\u201384.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"2233_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/ACO.0000000000000814","volume":"33","author":"PA Th\u00fcrmann","year":"2020","unstructured":"Th\u00fcrmann PA. Pharmacodynamics and pharmacokinetics in older adults. Curr Opin Anaesthesiol. 2020;33(1):109\u201313.","journal-title":"Curr Opin Anaesthesiol"},{"issue":"3","key":"2233_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/bja\/69.3.281","volume":"69","author":"GJ McCarthy","year":"1992","unstructured":"McCarthy GJ, Cooper R, Stanley JC, Mirakhur RK. Dose-response relationships for neostigmine antagonism of vecuronium-induced neuromuscular block in adults and the elderly. Br J Anaesth. 1992;69(3):281\u20133.","journal-title":"Br J Anaesth"},{"issue":"4","key":"2233_CR14","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1213\/ANE.0000000000001513","volume":"123","author":"PA Stewart","year":"2016","unstructured":"Stewart PA, Liang SS, Li QS, Huang ML, Bilgin AB, Kim D, Phillips S. The impact of residual neuromuscular blockade, oversedation, and hypothermia on adverse respiratory events in a Postanesthetic Care Unit: a prospective study of prevalence, predictors, and outcomes. Anesth Analg. 2016;123(4):859\u201368.","journal-title":"Anesth Analg"},{"issue":"1","key":"2233_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1185\/03007995.2015.1103213","volume":"32","author":"B Yu","year":"2016","unstructured":"Yu B, Ouyang B, Ge S, Luo Y, Li J, Ni D, Hu S, Xu H, Liu J, Min S, Li L, Ma Z, Xie K, Miao C, Wu X. RECITE\u2013China investigators. Incidence of postoperative residual neuromuscular blockade after general anesthesia: a prospective, multicenter, anesthetist-blind, observational study. Curr Med Res Opin. 2016;32(1):1\u20139.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"2233_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/ALN.0000000000004379","volume":"138","author":"SR Thilen","year":"2023","unstructured":"Thilen SR, Weigel WA, Todd MM, et al. 2023 American Society of Anesthesiologists practice guidelines for monitoring and antagonism of neuromuscular blockade: a report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade. Anesthesiology. 2023;138(1):13\u201341.","journal-title":"Anesthesiology"},{"issue":"1","key":"2233_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/ALN.0b013e3181c53863","volume":"112","author":"T Fuchs-Buder","year":"2010","unstructured":"Fuchs-Buder T, Meistelman C, Alla F, Grandjean A, Wuthrich Y, Donati F. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine. Anesthesiology. 2010;112(1):34\u201340.","journal-title":"Anesthesiology"},{"issue":"4","key":"2233_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.accpm.2015.11.008","volume":"35","author":"A Preault","year":"2016","unstructured":"Preault A, Capron F, Chantereau C, Donati F, Dimet J. Under sevoflurane anaesthesia, a reduced dose of neostigmine can antagonize a shallow neuromuscular block: a double-blind, randomised study. Anaesth Crit Care Pain Med. 2016;35(4):269\u201373.","journal-title":"Anaesth Crit Care Pain Med"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-023-02233-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-023-02233-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-023-02233-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T01:04:23Z","timestamp":1700442263000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-023-02233-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2233"],"URL":"https:\/\/doi.org\/10.1186\/s12871-023-02233-7","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]},"assertion":[{"value":"19 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of the Ethics Committee of the Third Xiangya Hospital (reference number [R22008]) and written informed consent was obtained from all participants. The authors declare that all experiments were performed in accordance with relevant guidelines and regulations (such as the Declaration of Helsinki).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"269"}}